Are you finding it increasingly challenging to manage your organization’s regulatory submission process? The entire process of developing a drug from preclinical research to marketing takes approximately [...]
Data is the lifeblood of the life sciences. As therapeutics, medical devices, and diagnostics advance from early-stage development into clinical testing and beyond, the scrutiny of reported data and [...]
The life sciences industry has rapidly changed over the past twenty years. Drug development, historically, used to rely on vertically-integrated institutions that spanned scientific functions. However, [...]
Developing new drugs is an expensive, time-consuming endeavor. A critical output of the drug development process, besides the compound itself, is data. As you may have read recently, Zolgensma™ re-surfaced [...]
Data drives the life sciences. Data supports the development of new products and enables agile decision making. But for a field so completely reliant on data, the industry is struggling to find methods [...]
Those who have worked in the life sciences industry have undoubtedly observed a sea of change in the discipline over the past twenty years. From new modalities (like CAR-T to microbiome) to external collaborations, [...]
The life sciences industry is responsible for the discovery, development, and commercialization of new medicines to treat disease. Over the past 20 years, the discipline has undergone massive changes. [...]
Sprawl happens when anyone and everyone can create a site or team, usually without oversight, planning, or any kind of f...
Last year, Capital One showed the world why data governance is so important when it was the victim of a massive data bre...
Chaos is never good for business, but the reality is that it’s the state in which many companies live on a daily basis...